Who is sponsoring NCT05216848?

NCT05216848 is sponsored by Comenius University.

What drugs are being tested in NCT05216848?

Interventions in NCT05216848: Wijma Delivery Expectancy Questionnaire, Clinical data collection.

What condition does NCT05216848 study?

NCT05216848 studies Serious Concerns.

Is NCT05216848 still recruiting?

NCT05216848 is currently completed. Last updated 1 May 2023.

Last reviewed 2023-05-01 · How we verify

NCT05216848: RiskfSBC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence and Risk Factors for Serious Birth Concerns in Unselected Population of Mothers

Completed Last updated 1 May 2023

What this trial tests

trial testing Wijma Delivery Expectancy Questionnaire in Serious Concerns in 700 participants. Completed in 30 March 2023.

Timeline

1 September 2019

Primary endpoint
1 December 2022

30 March 2023

Quick facts

Lead sponsor	Comenius University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	700
Start date	1 September 2019
Primary completion	1 December 2022
Estimated completion	30 March 2023
Sites	1 location across Slovakia

Drugs / interventions tested

Wijma Delivery Expectancy Questionnaire
Clinical data collection

Conditions studied

Serious Concerns — all drugs for Serious Concerns →

Sponsor

Comenius University

Who can join

Adults 18 to 50, female only, with Serious Concerns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the prevalence of significant concerns about childbirth and their impact on the course and outcome of childbirth. By identifying a group of mothers who have an excessive fear of childbirth, the occurrence of surgical births can be influenced by the right intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Comenius University trials

Trials by the same sponsor.

NCT07522905 — Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission · NA · not yet recruiting
NCT07446556 — Exercise Program in Women With Pudendal Neuralgia · NA · enrolling by invitation
NCT07465809 — Mental Health Resources and Employability in Healthcare · NA · completed
NCT07442838 — Clinical Outcomes and Complications in Two-stage Breast Reconstruction Using Microtextured and Nanotextured Expanders · active not recruiting
NCT06842615 — Prospective Evaluation of Diagnostic Performance of PanTum Detect Test in Adult Patients With Suspected or Confirmed Mac · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05216848 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Comenius University
Last refreshed: 1 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05216848.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing